Location History:
- New Hope, MN (US) (1982 - 1984)
- Maple Grove, MN (US) (1990 - 1998)
Company Filing History:
Years Active: 1982-1998
Title: Frank T. Kotula: Innovator in Medical Device Technology
Introduction
Frank T. Kotula is a notable inventor based in Maple Grove, MN (US), recognized for his significant contributions to the field of medical devices. With a total of 10 patents to his name, Kotula has made remarkable advancements in the design and functionality of percutaneous catheter directed occlusion devices.
Latest Patents
Among his latest patents, Kotula has developed innovative medical devices aimed at occluding abnormal openings in body organs. One of his notable inventions is a collapsible medical device made from heat treatable metal fabric. This device is designed to occlude conditions such as atrial septal defects (ASD), patent ductus arteriosus (PDA), and ventricular septal defects (VSD). The device is shaped through a heat treatment process within a mold, allowing it to maintain a preselected shape for effective deployment through a catheter. Another significant patent involves a method for forming intravascular occlusion devices, which can be collapsed for easy passage through a catheter, ensuring efficient delivery and deployment within a patient's body.
Career Highlights
Throughout his career, Frank T. Kotula has worked with various companies, including Microvena Corporation, where he has contributed to the development of cutting-edge medical technologies. His work has focused on enhancing the safety and efficacy of medical devices used in minimally invasive procedures.
Collaborations
Kotula has collaborated with esteemed professionals in the field, including Kurt Amplatz and Timothy Claude. These partnerships have fostered innovation and have played a crucial role in the advancement of medical device technology.
Conclusion
Frank T. Kotula's contributions to the medical device industry exemplify his dedication to improving patient care through innovative solutions. His patents reflect a commitment to advancing technology that addresses critical health challenges.